Source:http://linkedlifedata.com/resource/pubmed/id/20031245
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-3-8
|
pubmed:abstractText |
Our studies suggest that plasma soluble advanced glycation end products (sRAGEs) has significantly negative association with high sensitivity C-reactive protein (hs-CRP) in 245 type 2 diabetes patients without diagnosed coronary artery disease (CAD). sRAGE maybe act as a novel biomarker for predicting the atherosclerosis in diabetes at the early stage.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1872-8227
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e19-22
|
pubmed:meshHeading |
pubmed-meshheading:20031245-Aged,
pubmed-meshheading:20031245-C-Reactive Protein,
pubmed-meshheading:20031245-Coronary Artery Disease,
pubmed-meshheading:20031245-Diabetes Mellitus, Type 2,
pubmed-meshheading:20031245-Female,
pubmed-meshheading:20031245-Glycosylation End Products, Advanced,
pubmed-meshheading:20031245-Humans,
pubmed-meshheading:20031245-Male,
pubmed-meshheading:20031245-Middle Aged,
pubmed-meshheading:20031245-Regression Analysis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Plasma sRAGE is independently associated with high sensitivity C-reactive protein in type 2 diabetes without coronary artery disease.
|
pubmed:affiliation |
The Department of Endocrinology, Jiangsu Province Hospital of TCM, 155 Han-Zhong Road, Nanjing 210029, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|